相关产品推荐更多 >

CRISPLD1纯化的MaxPab小鼠源多克隆抗体(B01P)/CRISPLD1纯化的MaxPab小鼠源多克隆抗体(B01P)/CRISPLD1纯化的MaxPab小鼠源多克隆抗体(B01P)
询价
MIDN纯化的MaxPab小鼠源多克隆抗体(B01P)/MIDN纯化的MaxPab小鼠源多克隆抗体(B01P)/MIDN纯化的MaxPab小鼠源多克隆抗体(B01P)
询价
HAMP polyclonal antibody (A01)/HAMP polyclonal antibody (A01)/HAMP polyclonal antibody (A01)
询价
TNNI3 (phospho T142) polyclonal antibody/TNNI3 (phospho T142) polyclonal antibody/TNNI3 (phospho T142) polyclonal antibody
询价
KLHL25 单克隆抗体
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
查看datasheet
- 保质期:
1年
- 级别:
科研级别
- 库存:
100
- 供应商:
艾美捷科技
- 应用范围:
查看datasheet
- 抗体英文名:
Rat Complement Factor H Antibody, FITC Conjugate
- 抗体名:
Rat Complement Factor H Antibody, FITC Conjugate
Rat Complement Factor H 抗体, FITC偶联,Rat Complement Factor H Antibody, FITC Conjugate,
产品名称:Rat Complement Factor H 抗体, FITC偶联-Rat Complement Factor H Antibody, FITC Conjugate
产品货号:BGT-ANT-34834
产品规格:2x75ug

应用类型:Rat Complement Factor H 抗体, FITC偶联产品详情查看提供的产品datasheet。

Rat Complement Factor H 抗体, FITC偶联,Rat Complement Factor H Antibody, FITC Conjugate

Rat Complement Factor H 抗体, FITC偶联-Rat Complement Factor H Antibody, FITC ConjugateRat Complement Factor H 抗体, FITC偶联产品保存方式查看提供的产品datasheet。
点击:Rat Complement Factor H 抗体, FITC偶联-Rat Complement Factor H Antibody, FITC Conjugate更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Purification, Quantification, and Functional Analysis of Complement Factor H
Complement Factor H (FH) is an abundant, non-enzymic plasma/serum glycoprotein, which has a major role in regulating activation of the complement system. It can be purified from human plasma/serum by affinity chromatography, using
Factor H-related proteins (CFHRs) are plasma glycoproteins related in structure and antigenicity to each other and to the complement inhibitory protein factor H. Such proteins are found in most mammals but their number and domain composition
Anti-Factor H Autoantibodies Assay
of autoantibodies directed against Factor H (FH), the main plasmatic alternative complement pathway regulatory protein. Their presence induces an acquired functional FH deficiency. The anti-FH autoantibodies screening must be performed at the very onset
技术资料暂无技术资料 索取技术资料





